HS
KRYS icon

HighVista Strategies’s Krystal Biotech KRYS Stock Holding History

HighVista Strategies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$471K Buy
+1,824
New +$485K 0.13% 150
2025
Q1 		– Sell
-4,217
Closed -$661K – 158
2024
Q4 		$661K Buy
+4,217
New +$748K 0.25% 119
2024
Q2 		– Sell
-3,923
Closed -$698K – 145
2024
Q1 		$698K Buy
+3,923
New +$545K 0.25% 106
2023
Q4 		– Sell
-4,392
Closed -$509K – 136
2023
Q3 		$509K Buy
4,392
+1,862
+74% +$227K 0.24% 106
2023
Q2 		$297K Sell
2,530
-8,528
-77% -$871K 0.14% 133
2023
Q1 		$885K Hold
11,058
– – 0.72% 42
2022
Q4 		$876K Buy
11,058
+4,023
+57% +$299K 0.52% 57
2022
Q3 		$490K Sell
7,035
-5,190
-42% -$375K 0.28% 82
2022
Q2 		$803K Buy
+12,225
New +$760K 0.48% 48

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return